Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a member of a family of enzymes that function to add glutathione to target electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins, and products of oxidative stress. This action is an important step in detoxification of these compounds. This subfamily of enzymes has a particular role in protecting cells from reactive oxygen species and the products of peroxidation. Polymorphisms in this gene influence the ability of individuals to metabolize different drugs. This gene is located in a cluster of similar genes and pseudogenes on chromosome 6. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GSTA1 (Glutathione S-Transferase Alpha 1) is a Protein Coding gene. Diseases associated with GSTA1 include Dental Fluorosis and Hepatocellular Carcinoma. Among its related pathways are Drug metabolism - cytochrome P450 and Naphthalene metabolism. Gene Ontology (GO) annotations related to this gene include glutathione transferase activity. An important paralog of this gene is GSTA2.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH06J052803 | Promoter | 0.4 | EPDnew | 600.7 | +0.0 | 24 | 0.1 | RAD21 | GSTA1 GSTA2 piR-42671-002 | |
GH06J052802 | Promoter | 0.3 | Ensembl | 600.7 | +0.6 | 559 | 1 | GSTA1 piR-42671-002 GSTA2 | ||
GH06J052761 | Promoter/Enhancer | 1.5 | EPDnew Ensembl ENCODE | 12.7 | +40.9 | 40915 | 2 | GATAD2A CTCF TFE3 RCOR2 RXRB IRF2 CEBPA KMT2B SOX13 FOXA1 | GSTA2 GSTA1 piR-42671-001 TMEM14A | |
GH06J052814 | Enhancer | 1 | Ensembl ENCODE | 15.8 | -11.6 | -11588 | 1 | GATAD2A CTCF SOX13 RCOR2 RBFOX2 RXRB SP1 TRIM22 DPF2 ZNF600 | GSTA6P lnc-GSTA1-1 piR-45150 GSTA1 GSTA3 CILK1 GSTA5 | |
GH06J052787 | Enhancer | 0.9 | Ensembl ENCODE | 16.1 | +15.1 | 15128 | 2.7 | GATAD2A REST RXRB SP1 CEBPA SOX13 HMBOX1 EGR1 NFE2 FOXA2 | piR-53063-219 GSTA1 GSTA7P piR-42671-002 GSTA2 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0004364 | glutathione transferase activity | IBA,NAS | 1731620 |
GO:0004601 | peroxidase activity | IEA | -- |
GO:0004602 | glutathione peroxidase activity | IDA | 16624487 |
GO:0004769 | steroid delta-isomerase activity | IDA | 11152686 |
GO:0005504 | fatty acid binding | IPI | 16624487 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005737 | cytoplasm | IEA | -- |
GO:0005829 | cytosol | TAS | -- |
GO:0070062 | extracellular exosome | HDA | 19056867 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Glutathione metabolism |
Glutathione metabolism
.60
|
|
2 | Drug metabolism - cytochrome P450 | ||
3 | Metabolism |
.40
|
|
4 | Cytochrome P450 - arranged by substrate type | ||
5 | Fluid shear stress and atherosclerosis |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006693 | prostaglandin metabolic process | IDA | 9084911 |
GO:0006749 | glutathione metabolic process | IDA | 11851347 |
GO:0006805 | xenobiotic metabolic process | IBA | 21873635 |
GO:0030855 | epithelial cell differentiation | IEP | 21492153 |
GO:0043651 | linoleic acid metabolic process | IDA | 16624487 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Busulfan | Approved, Investigational | Pharma | Enzyme, substrate | 622 | ||
Glutathione | Approved, Investigational | Nutra | Target, Enzyme, substrate | 0 | ||
Cyclophosphamide | Approved, Investigational | Pharma | Nitrogen mustard alkylating agent and prodrug. | 3670 | ||
Azathioprine | Approved | Pharma | Enzyme, substrate | 227 | ||
Curcumin | Approved, Experimental, Investigational | Pharma | Enzyme, inhibitor | Tyrosinase inhibitor | 221 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene |
|
|
||||
(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene |
|
|
||||
(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene |
|
|
||||
(1S,2R)-Naphthalene 1,2-oxide |
|
|
||||
1,1-Dichloroethylene epoxide |
|
|
Compound | Action | Cas Number |
---|---|---|
Ezatiostat hydrochloride | GST inhibitor | 286942-97-0 |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | GSTA1 30 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Gsta2 30 |
|
||
Cow (Bos Taurus) |
Mammalia | GSTA2 30 31 |
|
ManyToMany | |
Mouse (Mus musculus) |
Mammalia | Gsta2 31 |
|
ManyToMany | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | -- 31 |
|
OneToMany | |
Oppossum (Monodelphis domestica) |
Mammalia | -- 31 |
|
ManyToMany | |
Dog (Canis familiaris) |
Mammalia | -- 31 |
|
OneToMany | |
Chicken (Gallus gallus) |
Aves | -- 31 |
|
ManyToMany | |
GSTA3 31 |
|
ManyToMany | |||
Lizard (Anolis carolinensis) |
Reptilia | -- 31 |
|
ManyToMany | |
-- 31 |
|
ManyToMany | |||
-- 31 |
|
ManyToMany | |||
-- 31 |
|
ManyToMany | |||
Zebrafish (Danio rerio) |
Actinopterygii | zgc:173962 31 |
|
ManyToMany | |
gstal 31 |
|
ManyToMany | |||
zgc:173961 31 |
|
ManyToMany | |||
Worm (Caenorhabditis elegans) |
Secernentea | gst-41 31 |
|
ManyToMany | |
gst-10 31 |
|
ManyToMany | |||
F56A4.3 31 |
|
ManyToMany | |||
Y45G12C.3 31 |
|
ManyToMany | |||
F56A4.4 31 |
|
ManyToMany | |||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 06 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
718439 | Benign: not provided | 52,796,178(-) | G/A | INTRON_VARIANT | |
726193 | Benign: not provided | 52,799,253(-) | G/A | SYNONYMOUS_VARIANT,FIVE_PRIME_UTR_VARIANT | |
747861 | Likely Benign: not provided | 52,796,280(-) | A/C | SYNONYMOUS_VARIANT,INTRON_VARIANT | |
rs1051578 | - | p.Thr19Ile | |||
rs1051745 | - | p.Pro113Gln |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv10661n54 | CNV | loss | 21841781 |
dgv1182e214 | CNV | gain | 21293372 |
dgv5961n100 | CNV | loss | 25217958 |
dgv5962n100 | CNV | loss | 25217958 |
dgv5963n100 | CNV | loss | 25217958 |
esv2436160 | CNV | deletion | 19546169 |
esv2656678 | CNV | deletion | 23128226 |
esv2666921 | CNV | deletion | 23128226 |
esv2732085 | CNV | deletion | 23290073 |
esv2732086 | CNV | deletion | 23290073 |
esv2752126 | CNV | gain | 17911159 |
esv2759429 | CNV | loss | 17122850 |
esv2760993 | CNV | gain | 21179565 |
esv2763990 | CNV | loss | 21179565 |
esv3609005 | CNV | loss | 21293372 |
esv3609008 | CNV | gain | 21293372 |
esv3890845 | CNV | gain | 25118596 |
esv4858 | OTHER | sequence alteration | 18987735 |
esv9378 | CNV | loss | 19470904 |
nsv1019011 | CNV | loss | 25217958 |
nsv1032774 | CNV | gain | 25217958 |
nsv436888 | CNV | insertion | 17901297 |
nsv462945 | CNV | loss | 19166990 |
nsv470818 | CNV | loss | 18288195 |
nsv482096 | CNV | gain | 20164927 |
nsv603106 | CNV | loss | 21841781 |
nsv970122 | CNV | duplication | 23825009 |
Disorder | Aliases | PubMed IDs |
---|---|---|
dental fluorosis |
|
|
hepatocellular carcinoma |
|
|